MPC
44
14
O
44
2
NAVI
41
12
IR
71
-12
HP
33
4
DGX
48
4
PCAR
52
2
SWK
55
3
WDC
58
4
AVGO
42
2
ADBE
55
4
NFLX
59
-2
RL
76
6
SCHW
61
3
SWKS
42
5
PNR
63
3
REGN
71
6
SWN
57
-3
EMR
39
2
IP
40
4
MPC
44
14
O
44
2
NAVI
41
12
IR
71
-12
HP
33
4
DGX
48
4
PCAR
52
2
SWK
55
3
WDC
58
4
AVGO
42
2
ADBE
55
4
NFLX
59
-2
RL
76
6
SCHW
61
3
SWKS
42
5
PNR
63
3
REGN
71
6
SWN
57
-3
EMR
39
2
IP
40
4
Financhill
Back

Neurocrine Biosciences Quote, Financials, Valuation and Earnings

Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!

Act now for your path to extra income!
Buy
53

NBIX
Neurocrine Biosciences

Last Price:
140.77
Seasonality Move:
8.72%

7 Day Trial

ALL ACCESS PASS

$ 7

7 Powerhouse Stocks to Buy and Hold Forever

Get it now.

Neurocrine Biosciences Price Quote

$140.77
+0.06 (+0.74%)
(Updated: May 4, 2024 at 6:29 AM ET)

Neurocrine Biosciences Key Stats

Buy
53
Neurocrine Biosciences (NBIX) is a Buy
Day range:
$139.23 - $141.88
52-week range:
$89.04 - $148.37
Dividend yield:
0%
P/E ratio:
56.97
P/S ratio:
7.23
P/B ratio:
5.93%
Volume:
615.1K
Avg. volume:
818.4K
1-year change:
42.68%
Market cap:
$14.2B
Revenue:
$1.9B
EPS:
$3.63

How Much Does Neurocrine Biosciences Make?

Is Neurocrine Biosciences Growing As A Company?

Neurocrine Biosciences Stock Price Performance

What Is Neurocrine Biosciences 52-Week High & Low?

Neurocrine Biosciences Price To Free Cash Flow

Is It Risky To Buy Neurocrine Biosciences?

Is Neurocrine Biosciences Cash Flow Positive?

  • What Is NBIX Cash Flow From Operations?
    Cash flow from operations (TTM) is $645.4M
  • What Is Neurocrine Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $127M
  • What Is Neurocrine Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$480M

Neurocrine Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    NBIX return on invested capital is 16.66%
  • What Is Neurocrine Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is 12.71%
  • What Is NBIX Return On Equity?
    ROE is a measure of profitability and is 18.2%

Neurocrine Biosciences Earnings Date & Stock Price

Neurocrine Biosciences Competitors

Neurocrine Biosciences Dividend Yield

Data Unavailable

Neurocrine Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -6.81%
Revenue: 22.57% 0.64%

Analyst Recommendations

Buy Recommendations: 16
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 157.44
Upside from Last Price: 11.89%

Major Shareholders

  • How many NBIX shares are owned by institutional investors?
    135.1M NBIX shares are owned by institutional investors
  • How many NBIX shares are owned by insiders?
    2.3M NBIX shares are owned by insiders